secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0001193125-23-181344
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra shareholders elect Brady and Joyce as Class III directors, approve 2023 equity plan
--------------------------------------------------------------------------------

- Director Todd C. Brady reelected with 21,007,679 votes for, 7,405,955 withheld.
- Director Martin J. Joyce elected with 16,126,225 votes for, 12,287,409 withheld.
- Ratification of BDO USA as auditor approved: 43,474,045 for, 25,820 against.
- Advisory vote on executive compensation approved: 27,710,251 for, 57,323 abstain.
- 2023 Equity Incentive Plan approved: 27,066,030 for, 1,293,014 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312523181344/0001193125-23-181344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312523181344/d431816d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-181344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer